In addition, JAK2 mutations may favor CVD by boosting innate immunity responses, and this may explain how JAK2-driven CHIP favors atherosclerosis and HF (see Figure 1 for a comprehensive mechanistic view of CHIP and cardiovascular risk). Here, STUB1 is linked to atherosclerosis.